Brief: Black Diamond Therapeutics Q3 basic EPS USD -0.45
06/11/2023 12:45
Nov 6 (Reuters) - Black Diamond Therapeutics Q3 net income USD -23.007 million. * Q3 basic EPS USD -0.45 * Q3 operating expenses USD 24.012 million * Q3 income from operations USD -24.012 million
Recent news on Black Diamond Therapeutics
See all newsBlack Diamond Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Black Diamond Therapeutics Q2 net loss narrows year over year
Black Diamond Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Black Diamond Therapeutics Q4 net loss narrows, full-year profit turns positive
U.S. STOCKS ON THE MOVE-Spirit AeroSystems, Boeing, Roblox